Supplementary figures and tables: Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis.docx
Supplementary Figure 6. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Network Meta-analysis Results for All-cause Mortality’
Supplementary Table 1. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Search Strategy’
Supplementary Table 2. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Population, Interventions and Comparisons, Outcomes, Study Design, and Time Period Selection Criteria’
Supplementary Table 3. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Process for Selecting Data among Kin Publications’
Supplementary Table 4. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Key Characteristics from Studies Included in the Network Meta-analysis’
Supplementary Table 5. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
‘Outcomes from Studies Included in the Network Meta-analysis’
PRISMA checklist. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis
|